Hepcinat is a direct-acting antiviral medication manufactured by Natco Pharma Ltd. (India).
Its active ingredient, Sofosbuvir 400 mg, is used in the treatment of chronic hepatitis C virus (HCV) infection across multiple genotypes.
Sofosbuvir is a nucleotide analog inhibitor of the HCV NS5B RNA-dependent RNA polymerase, an enzyme essential for viral replication.
By blocking this enzyme, Hepcinat prevents the virus from multiplying and helps clear it from the body.
The medicine is used as part of combination therapy with other antivirals such as Ledipasvir, Daclatasvir, or Velpatasvir, depending on the HCV genotype.
Store below 30 °C in a dry place, away from direct sunlight.
Keep out of reach of children.